Fig. 4From: High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatinTime-dependent ROC analysis for PLR, NLR, and LMR according to overall survivalBack to article page